Philippe Debruyne

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens et al. · Journal of the American Heart Association · 2016 · 200 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Mechanisms of Neointima Formation and Remodeling in the Porcine Coronary Artery

Thomas Christen, Vitali Verin, Marie‐Luce Bochaton‐Piallat et al. · Circulation · 2001 · 161 citations · Full text

Life Sciences, Cardiology, Cell Biology +15

Evaluation and Reduction of Asymptomatic Cerebral Embolism in Ablation of Atrial Fibrillation, But High Prevalence of Chronic Silent Infarction

Atul Verma, Philippe Debruyne, Stefano Nardi et al. · Circulation Arrhythmia and Electrophysiology · 2013 · 137 citations

Medicine, Cardiology, Surgery +17

Unifocal Right-Sided Ablation Treatment for Neurally Mediated Syncope and Functional Sinus Node Dysfunction Under Computed Tomographic Guidance

Philippe Debruyne, Tom Rossenbacker, Christine Collienne et al. · Circulation Arrhythmia and Electrophysiology · 2018 · 111 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +9